SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sorenson John Bradley

(Last)

(First)

(Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH

01752-1234

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2015

3. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Glob Ops & Qual

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Deferred Stock Units	02/16/2015⁽¹⁾	02/16/2015⁽¹⁾	Common Stock	6,103⁽²⁾	⁽³⁾	D
Deferred Stock Units	02/24/2019⁽⁴⁾	02/24/2019⁽⁴⁾	Common Stock	7,645⁽⁵⁾	⁽⁶⁾	D
Deferred Stock Units	02/27/2017⁽⁷⁾	02/27/2017⁽⁷⁾	Common Stock	21,498⁽⁸⁾	⁽⁶⁾	D
Deferred Stock Units	02/28/2016⁽⁹⁾	02/28/2016⁽⁹⁾	Common Stock	6,284⁽¹⁰⁾	⁽⁶⁾	D
Deferred Stock Units	02/28/2018⁽¹¹⁾	02/28/2018⁽¹¹⁾	Common Stock	21,652⁽¹²⁾	⁽⁶⁾	D
Deferred Stock Units	05/10/2015⁽¹³⁾	05/10/2015⁽¹³⁾	Common Stock	3,030⁽¹⁴⁾	⁽⁶⁾	D
Stock Option (Right to Buy)	⁽¹⁵⁾	02/28/2021	Common Stock	34,938	$7.16	D
Stock Option (Right to Buy)	⁽¹⁶⁾	02/24/2024	Common Stock	20,000	$13.08	D
Stock Option (Right to Buy)	⁽¹⁷⁾	10/25/2015	Common Stock	10,000	$24.35	D

Explanation of Responses:

1. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.

2. This amount represents the unvested portion of deferred stock units (DSUs) awarded on February 16, 2010, which will continue to vest in one remaining installment on the anniversary of the date of grant.

3. Each DSU represents the Company's commitment to issue one share of Boston Scientific common stock.

4. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

5. This amount represents the unvested portion of DSUs awarded on February 24, 2014, which will continue to vest in five remaining installment on the anniversary of the date of grant.

6. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

7. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.

8. This amount represents the unvested portion of DSUs awarded on February 27, 2012, which will continue to vest in three remaining installments on the anniversary of the date of grant.

9. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.

10. This amount represents the unvested portion of DSUs awarded on February 28, 2011, which will continue to vest in two remaining installments on the anniversary of the date of grant.

11. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.

12. This amount represents the unvested portion of DSUs awarded on February 28, 2013, which will continue to vest in four remaining installments on the anniversary of the date of grant.

13. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on May 10, 2011, the first anniversary of the date of grant.

14. This amount represents the unvested portion of DSUs awarded on May 10, 2010, which will continue to vest in one remaining installment on the anniversary of the date of grant.

15. Grant to the reporting person of an option to purchase 34,938 shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.

16. Grant to the reporting person of an option to purchase 20,000 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

17. Grant to the reporting person of an option to purchase 10,000 shares of common stock vesting in four equal annual installments beginning on October 25, 2006 the first anniversary of the date of grant.

Remarks:

sorensonpoa.txt

	/s/ Lee G. Giguere, Attorney-in-Fact	01/06/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.